The results of meta-analysis by Li et al across 7 studies (35 thousand patients) suggest that post-diagnosis aspirin therapy improves CRC overall survival, especially for patients with tumors positive for PTGS2 (COX-2) expression and PIK3CA mutations [187]. The gene discussed is PIK3CA; the disease is colorectal carcinoma.